2024. In Silico Characterization of a Novel Bioactive Compound derived from Psidium guajava 4-[5-(Pyridin-4-yl)-1,2,4-oxadiazol-3-yl]-1,2,5-oxadiazol-3-amine: A Potential Inhibitor for Targeting Signaling Proteins involved in Diabetes Development. International Journal of Pharmaceutical Sciences and Drug Research. 16, 2 (Mar. 2024), 180–190. DOI:https://doi.org/10.25004/IJPSDR.2024.160207.